Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

Mucormycosis in haematological patients: case report and results of prospective study in Saint Petersburg, Russia.

Klimko NN, Khostelidi SN, Volkova AG, Popova MO, Bogomolova TS, Zuborovskaya LS, Kolbin AS, Medvedeva NV, Zuzgin IS, Simkin SM, Vasilyeva NV, Afanasiev BV.

Mycoses. 2014 Dec;57 Suppl 3:91-6. doi: 10.1111/myc.12247. Epub 2014 Sep 3.

PMID:
25187314
2.

Comparative characteristics of platelet lysates from different donors.

Kalmykova NV, Skorobogataya EV, Berestovoy MA, Kruglyakov PV, Estrina MA, Afanasiev BV, Polintsev DG.

Bull Exp Biol Med. 2011 Aug;151(4):547-9.

PMID:
22448388
3.

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.

Coiffier B, Osmanov EA, Hong X, Scheliga A, Mayer J, Offner F, Rule S, Teixeira A, Walewski J, de Vos S, Crump M, Shpilberg O, Esseltine DL, Zhu E, Enny C, Theocharous P, van de Velde H, Elsayed YA, Zinzani PL; LYM-3001 study investigators.

Lancet Oncol. 2011 Aug;12(8):773-84. doi: 10.1016/S1470-2045(11)70150-4. Epub 2011 Jul 1.

PMID:
21724462
4.

Effect of FCGR2A and FCGR3A variants on CLL outcome.

Dornan D, Spleiss O, Yeh RF, Duchateau-Nguyen G, Dufour A, Zhi J, Robak T, Moiseev SI, Dmoszynska A, Solal-Celigny P, Warzocha K, Loscertales J, Catalano J, Afanasiev BV, Larratt L, Rossiev VA, Bence-Bruckler I, Geisler CH, Montillo M, Wenger MK, Weisser M.

Blood. 2010 Nov 18;116(20):4212-22. doi: 10.1182/blood-2010-03-272765. Epub 2010 Aug 12.

5.

Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia.

Robak T, Dmoszynska A, Solal-CĂ©ligny P, Warzocha K, Loscertales J, Catalano J, Afanasiev BV, Larratt L, Geisler CH, Montillo M, Zyuzgin I, Ganly PS, Dartigeas C, Rosta A, Maurer J, Mendila M, Saville MW, Valente N, Wenger MK, Moiseev SI.

J Clin Oncol. 2010 Apr 1;28(10):1756-65. doi: 10.1200/JCO.2009.26.4556. Epub 2010 Mar 1.

6.

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.

Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR; International Vidaza High-Risk MDS Survival Study Group.

Lancet Oncol. 2009 Mar;10(3):223-32. doi: 10.1016/S1470-2045(09)70003-8. Epub 2009 Feb 21.

7.

High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis.

Shevchenko YL, Novik AA, Kuznetsov AN, Afanasiev BV, Lisukov IA, Kozlov VA, Rykavicin OA, Ionova TI, Melnichenko VY, Fedorenko DA, Kulagin AD, Shamanski SV, Ivanov RA, Gorodokin G.

Exp Hematol. 2008 Aug;36(8):922-8. doi: 10.1016/j.exphem.2008.03.001. Epub 2008 May 12.

PMID:
18468768
8.

Mosquito densonucleosis virus non-structural protein NS2 is necessary for a productive infection.

Azarkh E, Robinson E, Hirunkanokpun S, Afanasiev B, Kittayapong P, Carlson J, Corsini J.

Virology. 2008 Apr 25;374(1):128-37. doi: 10.1016/j.virol.2007.11.035. Epub 2008 Jan 28.

9.

Mosquito densonucleosis viruses cause dramatically different infection phenotypes in the C6/36 Aedes albopictus cell line.

Paterson A, Robinson E, Suchman E, Afanasiev B, Carlson J.

Virology. 2005 Jul 5;337(2):253-61.

10.

Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins.

Konopleva M, Konoplev S, Hu W, Zaritskey AY, Afanasiev BV, Andreeff M.

Leukemia. 2002 Sep;16(9):1713-24.

11.

Aedes aegypti transducing densovirus pathogenesis and expression in Aedes aegypti and Anopheles gambiae larvae.

Ward TW, Jenkins MS, Afanasiev BN, Edwards M, Duda BA, Suchman E, Jacobs-Lorena M, Beaty BJ, Carlson JO.

Insect Mol Biol. 2001 Oct;10(5):397-405.

PMID:
11881803
12.

Characterization of the structural gene promoter of Aedes aegypti densovirus.

Ward TW, Kimmick MW, Afanasiev BN, Carlson JO.

J Virol. 2001 Feb;75(3):1325-31.

13.

Densovirinae as gene transfer vehicles.

Afanasiev B, Carlson J.

Contrib Microbiol. 2000;4:33-58. Review.

PMID:
10941569
14.

Transduction of Aedes aegypti mosquitoes with vectors derived from Aedes densovirus.

Afanasiev BN, Ward TW, Beaty BJ, Carlson JO.

Virology. 1999 Apr 25;257(1):62-72.

15.

Packaging of AeDNV-GFP transducing virus by expression of densovirus structural proteins from a sindbis virus expression system.

Allen-Miura TM, Afanasiev BN, Olson KE, Beaty BJ, Carlson JO.

Virology. 1999 Apr 25;257(1):54-61.

16.

Gene expression and regulation from the p7 promoter of Aedes densonucleosis virus.

Kimmick MW, Afanasiev BN, Beaty BJ, Carlson JO.

J Virol. 1998 May;72(5):4364-70.

17.

Ultraviolet irradiation induces multiple DNA double-strand breaks and apoptosis in normal granulocytes and chronic myeloid leukaemia blasts.

Bogdanov KV, Chukhlovin AB, Zaritskey AY, Frolova OI, Afanasiev BV.

Br J Haematol. 1997 Sep;98(4):869-72.

PMID:
9326181
18.

Autonomous parvovirus and densovirus gene vectors.

Corsini J, Afanasiev B, Maxwell IH, Carlson JO.

Adv Virus Res. 1996;47:303-51. Review. No abstract available.

PMID:
8895835
19.

Densovirus of Aedes aegypti as an expression vector in mosquito cells.

Afanasiev BN, Kozlov YV, Carlson JO, Beaty BJ.

Exp Parasitol. 1994 Nov;79(3):322-39.

PMID:
7957754
20.

Our first experience of transfusion support in allogenic bone marrow transplantations.

Fregatova L, Volkova O, Platonova G, Afanasiev B.

Beitr Infusionsther Transfusionsmed. 1994;32:445-7.

PMID:
9422124
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk